FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+41.98%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$509M
AUM Growth
+$509M
(+19%)
Cap. Flow
-$97.8M
Cap. Flow
% of AUM
-19.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
3
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$7.75M |
Top Sells
| 1 |
10x Genomics
TXG
|
$96.8M |
| 2 |
Insmed
INSM
|
$3.79M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.43M |
| 4 |
Regenxbio
RGNX
|
$1.54M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $492M | 96.63% | 5,503,528 -1,083,725 | -16% | -$96.8M |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $13.9M | 2.72% | 862,402 +482,421 | +127% | +$7.75M |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.31M | 0.65% | 34,784 | – | – |
|
|
4
Insmed
INSM
$28.8B
| – | – | -236,547 | Closed | -$3.79M |
|
|
5
Regenxbio
RGNX
$451M
| – | – | -47,443 | Closed | -$1.54M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – | -253,698 | Closed | -$3.43M |
|